PFE Oct 2024 31.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 12:44PM EDT. Market open.
| Previous close | 0.8000 |
| Open | 0.7000 |
| Bid | 0.7000 |
| Ask | 0.7300 |
| Strike | 31.00 |
| Expiry date | 2024-10-18 |
| Day's range | 0.7000 - 0.7000 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.1k |
Yahoo FinanceNovavax stock doubles after Sanofi deal marks 'new chapter' for company
Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
ZacksPharma Stock Roundup: PFE DMD Study Patient Death, FDA Panel Meet for LLY's Donanemab
Pfizer (PFE) reports the death of a participant in a mid-stage study of its Duchenne drug. An FDA panel meeting to discuss Eli Lilly's (LLY) donanemab is set to take place on Jun 10.
GuruFocus.comDecoding Pfizer Inc (PFE): A Strategic SWOT Insight
Insightful Analysis of Pfizer Inc's Financial Health and Strategic Position
© 2024 Yahoo. All rights reserved.